Tech Company Financing Transactions

NMD Pharma Funding Round

NMD Pharma closed a $81.9 million Series B venture capital round on 11/16/2023. Investors included Jeito Capital, INKEF Capital and Lundbeckfonden BioCapital.

Transaction Overview

Company Name
Announced On
11/16/2023
Transaction Type
Venture Equity
Amount
$81,880,000
Round
Series B
Proceeds Purpose
Proceeds from the financing will be used to complete three Phase 2 studies with NMD670, the company's lead ClC-1 inhibitor.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
405 Waltham St. #391
Lexington, MA 02421
USA
Phone
Undisclosed
Email Address
Overview
NMD Pharma discovers and develops novel therapeutics for neuromuscular diseases. NMD Pharma has a unique experimental platform focusing on ion channel function and electrophysiology of skeletal muscle. We develop small molecule inhibitors of skeletal muscle-specific ClC-1 ion channels that have a promising therapeutic potential in a range of neuromuscular diseases in which muscle activation is failing leading to muscle weakness and excessive fatigue that compromise the ability of patients to conduct essential human behaviour and cause lack of independence.
Profile
NMD Pharma LinkedIn Company Profile
Social Media
NMD Pharma Company Twitter Account
Company News
NMD Pharma News
Facebook
NMD Pharma on Facebook
YouTube
NMD Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Pedersen
  Thomas Pedersen LinkedIn Profile  Thomas Pedersen Twitter Account  Thomas Pedersen News  Thomas Pedersen on Facebook
Chief Operating Officer
Thomas Petersen
  Thomas Petersen LinkedIn Profile  Thomas Petersen Twitter Account  Thomas Petersen News  Thomas Petersen on Facebook
Co-Founder
Ole Nielsen
  Ole Nielsen LinkedIn Profile  Ole Nielsen Twitter Account  Ole Nielsen News  Ole Nielsen on Facebook
Co-Founder
Claus Olesen
  Claus Olesen LinkedIn Profile  Claus Olesen Twitter Account  Claus Olesen News  Claus Olesen on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/16/2023: Taproot Wizards venture capital transaction
Next: 11/16/2023: Artifact Lab venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary